ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199

Product List

Home / ARPOD-CV DRY SYP

ALKANOL

Product Packing: 100 ML

Product Composition: Disodium Hydrogen Citrate

Product Price: MRP : 79.69

ALKANOL

Disodium Hydrogen Citrate | SYP 100 ML

ALKANOL is an oral syrup containing Disodium Hydrogen Citrate. Disodium Hydrogen Citrate is a systemic and urinary alkalinizing agent used in selected clinical situations where increasing urinary pH is appropriate. Use should follow the current approved product label and healthcare professional guidance.

After absorption and metabolism, citrate contributes an alkalinizing effect that can increase urinary pH. This may be useful in selected urinary conditions, but the appropriate indication, dose and duration depend on the patient's clinical status. The supplied brief does not provide the strength or a per-volume basis, so the exact concentration per measured dose must be verified from the approved product label.

Composition

Each labelled dose contains:

· Disodium Hydrogen Citrate - as per approved product specification

· Syrup base / excipients - q.s.

· The supplied brief does not provide the Disodium Hydrogen Citrate strength or a per-volume basis; exact concentration per ml/measured dose must be verified from the approved product label.

Dosage form: Oral Syrup

Pack size: 100 ml

Uses of ALKANOL

ALKANOL may be used as a urinary alkalinizing preparation in selected conditions where increasing urinary pH is clinically appropriate, according to the approved label and professional guidance.

· Helps increase urinary pH through an alkalinizing effect

· May be used as supportive therapy in selected conditions associated with acidic urine where specifically indicated

· May be used in certain urinary-stone management or prevention strategies when the stone type and clinical situation make alkalinization appropriate

· Can be part of individualized management for selected urinary symptoms or metabolic conditions under professional supervision

Painful urination, fever, flank pain, blood in urine, reduced urine output, recurrent urinary symptoms or suspected stones require appropriate medical evaluation.

How ALKANOL Works

ALKANOL provides Disodium Hydrogen Citrate, an alkalinizing citrate salt:

Citrate is metabolized to bicarbonate equivalents, contributing to systemic and urinary alkalinization.

Increasing urinary pH can alter the urinary environment and may be therapeutically useful in selected conditions.

The effect depends on the exact dose, renal function, hydration, diet, underlying condition and concurrent medicines.

Urinary alkalinization is not suitable for every urinary disorder or every type of stone; diagnosis and monitoring are important.

Urine pH, electrolytes or other laboratory parameters may require monitoring when clinically indicated, especially with prolonged therapy.

Dosage and Direction for Use

Use ALKANOL according to the approved product label or healthcare professional's advice. The supplied brief does not state the Disodium Hydrogen Citrate strength or serving volume, so no per-ml or per-5-ml dose has been inferred.

Measure the recommended quantity accurately with a calibrated measuring cup, spoon or oral syringe as appropriate.

If directed by the approved label, the measured dose may be diluted with water and taken as instructed. Maintain appropriate hydration unless fluid intake has been medically restricted.

Do not exceed the recommended dose or duration. Patients with kidney, heart or electrolyte disorders require individualized professional guidance.

Possible Side Effects

Possible adverse effects of citrate alkalinizing preparations may include:

· Nausea, vomiting, abdominal discomfort or diarrhoea

· Increased sodium intake may be clinically relevant in susceptible patients

· Excessive alkalinization can disturb acid-base or electrolyte balance

· Fluid retention or worsening of edema may occur in sodium-sensitive patients depending on total sodium exposure

· Seek medical attention for marked weakness, confusion, persistent vomiting, swelling, breathing difficulty, reduced urine output or other serious symptoms.

Any persistent or troublesome adverse effect should be discussed with a healthcare professional.

Precautions and Contraindications

· Review the complete approved label before use, particularly in patients with kidney disease, heart disease, hypertension, edema or disorders of acid-base/electrolyte balance.

· Avoid use in patients with known hypersensitivity to Disodium Hydrogen Citrate or any formulation excipient.

· Because the product contains a sodium citrate salt, total sodium exposure should be considered in patients requiring sodium restriction.

· Patients with impaired renal function may be at increased risk of electrolyte or acid-base disturbances and require professional assessment.

· Urinary alkalinization should not be used indiscriminately for urinary tract symptoms or stones without considering the underlying diagnosis and stone type.

· Pregnancy, breastfeeding, infants, children and patients with significant chronic illness require individualized professional guidance.

· Check sweeteners, flavours, preservatives and sodium content on the final approved label.

· Keep out of reach of children and store according to the approved pack instructions.

· Drug Interaction Considerations

· Changing urinary pH can alter the renal elimination of some medicines. Sodium-containing alkalinizing therapy may also be relevant to medicines or conditions affected by sodium/fluid balance. Review the complete medication list and current product-specific interaction guidance.

· Provide the healthcare professional with a complete list of prescription medicines, OTC urinary products, antacids and supplements before regular use.

Business Growth Opportunity with ALKANOL

ALKANOL offers pharmaceutical distributors and healthcare entrepreneurs an opportunity to add a Disodium Hydrogen Citrate oral syrup in a convenient 100 ml pack to their urinary-care and supportive-therapy portfolio.

Urinary alkalinizing preparations are an established therapeutic segment. Promotion should remain consistent with the final approved composition, indications, permitted claims, ethical pharmaceutical practice and applicable regulations.

Key Business Advantages

· Disodium Hydrogen Citrate formulation

· Urinary alkalinizing product concept

· Convenient oral syrup dosage form

· 100 ml pack

· Suitable addition to urinary-care portfolios subject to the approved formulation and indications

· Opportunity for ethical promotion through appropriate healthcare channels

PCD Pharma Franchise Opportunity for ALKANOL

Ethics Medinova Private Limited offers PCD Pharma Franchise opportunities for ALKANOL in selected territories across India, subject to availability, applicable regulations and mutually agreed business terms.

Franchise partners may benefit from the company's product portfolio, promotional support, supply coordination and business assistance.

Franchise Support May Include

· Monopoly-based territory opportunities, subject to availability

· Promotional materials and visual aids consistent with approved claims

· Product information and marketing support

· Reliable supply coordination

· Access to a growing pharmaceutical product portfolio

· Professional partner assistance

Partner with Ethics Medinova to explore PCD Pharma Franchise opportunities for ALKANOL and other quality-focused healthcare products.

Third-Party Manufacturing Support for Disodium Hydrogen Citrate Syrup

Ethics Medinova also supports eligible businesses exploring third-party manufacturing of formulations similar to ALKANOL under their own brand, subject to applicable drug licensing, regulatory and manufacturing requirements.

Our third-party manufacturing support may include:

· Customized approved strength, flavour and pack requirements, subject to regulatory feasibility

· Private-label manufacturing opportunities

· Customized packaging and branding support

· Product label and pack configuration assistance

· Manufacturing coordination through suitable licensed facilities

· Support for documentation and applicable regulatory requirements

This service may be suitable for eligible pharmaceutical companies seeking to expand an appropriately licensed urinary-care oral-syrup portfolio.

Frequently Asked Questions About ALKANOL

1. What is ALKANOL?

ALKANOL is a 100 ml oral syrup containing Disodium Hydrogen Citrate according to the supplied product brief.

2. What is Disodium Hydrogen Citrate used for?

It is an alkalinizing citrate salt used in selected clinical situations where increasing urinary pH is appropriate. Exact approved indications should be confirmed from the product label.

3. How does ALKANOL work?

Citrate contributes bicarbonate equivalents after metabolism, producing an alkalinizing effect that can increase urinary pH.

4. Can ALKANOL be used for kidney stones?

Urinary alkalinization can be useful in selected stone-management strategies, but it is not appropriate for every stone type. Diagnosis and professional guidance are important.

5. Does ALKANOL contain sodium?

Disodium Hydrogen Citrate is a sodium-containing citrate salt. Patients who need sodium restriction should review the product's sodium contribution with a healthcare professional.

6. How should ALKANOL be taken?

Follow the approved label or healthcare professional's directions and measure the recommended serving accurately. The supplied brief does not provide the ingredient strength or serving-volume basis.

7. Is a PCD Pharma Franchise available for ALKANOL?

Yes. Ethics Medinova offers PCD Pharma Franchise opportunities for selected products and territories, subject to availability, applicable regulations and mutually agreed terms.

8. Can this formulation be manufactured under my own brand?

Eligible businesses interested in a similar Disodium Hydrogen Citrate syrup may explore third-party manufacturing and private-label support with Ethics Medinova, subject to applicable drug licensing and regulatory requirements.

Disclaimer

ALKANOL product information in this document is for general professional and business information. The supplied product brief states Disodium Hydrogen Citrate, SYP 100 ML, but does not provide the ingredient strength or measured serving volume. No per-ml or per-5-ml concentration has therefore been inferred. Exact composition, concentration per measured dose, sodium content, approved age range, indications, dosage, contraindications, warnings, interactions, excipients, monitoring requirements and regulatory status must be verified against the current approved product label before manufacture, promotion, recommending, dispensing or use. Urinary symptoms and suspected stones may require diagnostic assessment, and urinary alkalinization is not appropriate for every condition. This document is not a substitute for professional medical advice.

Dosage Form

Therapy Wise

ALKANOL

ALKANOL

Disodium Hydrogen Citrate | SYP 100 ML

Composition

Pack size: 100 ml

Painful urination, fever, flank pain, blood in urine, reduced urine output, recurrent urinary symptoms or suspected stones require appropriate medical evaluation.

The effect depends on the exact dose, renal function, hydration, diet, underlying condition and concurrent medicines.

If directed by the approved label, the measured dose may be diluted with water and taken as instructed. Maintain appropriate hydration unless fluid intake has been medically restricted.

· Seek medical attention for marked weakness, confusion, persistent vomiting, swelling, breathing difficulty, reduced urine output or other serious symptoms.

· Keep out of reach of children and store according to the approved pack instructions.

· Provide the healthcare professional with a complete list of prescription medicines, OTC urinary products, antacids and supplements before regular use.

Urinary alkalinizing preparations are an established therapeutic segment. Promotion should remain consistent with the final approved composition, indications, permitted claims, ethical pharmaceutical practice and applicable regulations.

· Opportunity for ethical promotion through appropriate healthcare channels

Franchise partners may benefit from the company's product portfolio, promotional support, supply coordination and business assistance.

Partner with Ethics Medinova to explore PCD Pharma Franchise opportunities for ALKANOL and other quality-focused healthcare products.

This service may be suitable for eligible pharmaceutical companies seeking to expand an appropriately licensed urinary-care oral-syrup portfolio.

Frequently Asked Questions About ALKANOL

ALKANOL is a 100 ml oral syrup containing Disodium Hydrogen Citrate according to the supplied product brief.

It is an alkalinizing citrate salt used in selected clinical situations where increasing urinary pH is appropriate. Exact approved indications should be confirmed from the product label.

Citrate contributes bicarbonate equivalents after metabolism, producing an alkalinizing effect that can increase urinary pH.

Urinary alkalinization can be useful in selected stone-management strategies, but it is not appropriate for every stone type. Diagnosis and professional guidance are important.

Disodium Hydrogen Citrate is a sodium-containing citrate salt. Patients who need sodium restriction should review the product's sodium contribution with a healthcare professional.

Follow the approved label or healthcare professional's directions and measure the recommended serving accurately. The supplied brief does not provide the ingredient strength or serving-volume basis.

Yes. Ethics Medinova offers PCD Pharma Franchise opportunities for selected products and territories, subject to availability, applicable regulations and mutually agreed terms.

Eligible businesses interested in a similar Disodium Hydrogen Citrate syrup may explore third-party manufacturing and private-label support with Ethics Medinova, subject to applicable drug licensing and regulatory requirements.

Dosage Form

Therapy Wise

ALKANOL

ALKANOL

Disodium Hydrogen Citrate | SYP 100 ML

Composition

Pack size: 100 ml

Painful urination, fever, flank pain, blood in urine, reduced urine output, recurrent urinary symptoms or suspected stones require appropriate medical evaluation.

The effect depends on the exact dose, renal function, hydration, diet, underlying condition and concurrent medicines.

If directed by the approved label, the measured dose may be diluted with water and taken as instructed. Maintain appropriate hydration unless fluid intake has been medically restricted.

· Seek medical attention for marked weakness, confusion, persistent vomiting, swelling, breathing difficulty, reduced urine output or other serious symptoms.

· Keep out of reach of children and store according to the approved pack instructions.

· Provide the healthcare professional with a complete list of prescription medicines, OTC urinary products, antacids and supplements before regular use.

Urinary alkalinizing preparations are an established therapeutic segment. Promotion should remain consistent with the final approved composition, indications, permitted claims, ethical pharmaceutical practice and applicable regulations.

· Opportunity for ethical promotion through appropriate healthcare channels

Franchise partners may benefit from the company's product portfolio, promotional support, supply coordination and business assistance.

Partner with Ethics Medinova to explore PCD Pharma Franchise opportunities for ALKANOL and other quality-focused healthcare products.

This service may be suitable for eligible pharmaceutical companies seeking to expand an appropriately licensed urinary-care oral-syrup portfolio.

Frequently Asked Questions About ALKANOL

ALKANOL is a 100 ml oral syrup containing Disodium Hydrogen Citrate according to the supplied product brief.

It is an alkalinizing citrate salt used in selected clinical situations where increasing urinary pH is appropriate. Exact approved indications should be confirmed from the product label.

Citrate contributes bicarbonate equivalents after metabolism, producing an alkalinizing effect that can increase urinary pH.

Urinary alkalinization can be useful in selected stone-management strategies, but it is not appropriate for every stone type. Diagnosis and professional guidance are important.

Disodium Hydrogen Citrate is a sodium-containing citrate salt. Patients who need sodium restriction should review the product's sodium contribution with a healthcare professional.

Follow the approved label or healthcare professional's directions and measure the recommended serving accurately. The supplied brief does not provide the ingredient strength or serving-volume basis.

Yes. Ethics Medinova offers PCD Pharma Franchise opportunities for selected products and territories, subject to availability, applicable regulations and mutually agreed terms.

Eligible businesses interested in a similar Disodium Hydrogen Citrate syrup may explore third-party manufacturing and private-label support with Ethics Medinova, subject to applicable drug licensing and regulatory requirements.

We value your privacy

Get the Product Details